(PC) Williams v. Ogbuehi

District Court, E.D. California·Decided April 3, 2020·No. 1:19-cv-00855·Unknown

Opinion

GERRY WILLIAMS, Case No. 1:19-cv-00855-EPG (PC)

Plaintiff, FINDINGS AND RECOMMENDATIONS, v. RECOMMENDING THAT THIS ACTION BE DISMISSED FOR FAILURE TO STATE A CLEMENT OGBUEHI, et al., CLAIM

Defendants. (ECF NO. 12) OBJECTIONS, IF ANY, DUE WITHIN TWENTY-ONE (21) DAYS

ORDER DIRECTING THE CLERK OF COURT TO ASSIGN A DISTRICT JUDGE Gerry Williams (“Plaintiff”) is a state prisoner proceeding pro se and in forma pauperis in this civil rights action filed pursuant to 42 U.S.C. § 1983. Plaintiff filed the complaint commencing this action on June 19, 2019. (ECF No. 1). The Court screened Plaintiff’s complaint, provided the relevant legal standards, and gave Plaintiff leave to amend. (ECF No. 11). Plaintiff filed a First Amended Complaint on November 8, 2019 (ECF No. 12), which is before this Court for screening. For the reasons set forth below, the Court recommends that this action be dismissed for failure to state a claim. Plaintiff has twenty-one days from the date of service of these findings and recommendations to file his objections. The Court is required to screen complaints brought by prisoners seeking relief against a governmental entity or officer or employee of a governmental entity. 28 U.S.C. § 1915A(a). The Court must dismiss a complaint or portion thereof if the prisoner has raised claims that are legally “frivolous or malicious,” that fail to state a claim upon which relief may be granted, or that seek monetary relief from a defendant who is immune from such relief. 28 U.S.C. § 1915A(b)(1), (2). As Plaintiff is proceeding in forma pauperis (ECF No. 7), the Court may also screen the complaint under 28 U.S.C. § 1915. “Notwithstanding any filing fee, or any portion thereof, that may have been paid, the court shall dismiss the case at any time if the court determines that the action or appeal fails to state a claim upon which relief may be granted.” 28 U.S.C. § 1915(e)(2)(B)(ii). A complaint is required to contain “a short and plain statement of the claim showing that the pleader is entitled to relief.” Fed. R. Civ. P. 8(a)(2). Detailed factual allegations are not required, but “[t]hreadbare recitals of the elements of a cause of action, supported by mere conclusory statements, do not suffice.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (citing Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 555 (2007)). Plaintiff must set forth “sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” Id. (quoting Twombly, 550 U.S. at 570). The mere possibility of misconduct falls short of meeting this plausibility standard. Id. at 679. While a plaintiff’s allegations are taken as true, courts “are not required to indulge unwarranted inferences.” Doe I v. Wal-Mart Stores, Inc., 572 F.3d 677, 681 (9th Cir. 2009) (internal quotation marks and citation omitted). Additionally, a plaintiff’s legal conclusions are not accepted as true. Iqbal, 556 U.S. at 678. Pleadings of pro se plaintiffs “must be held to less stringent standards than formal pleadings drafted by lawyers.” Hebbe v. Pliler, 627 F.3d 338, 342 (9th Cir. 2010) (holding that pro se complaints should continue to be liberally construed after Iqbal). Plaintiff’s First Amended Complaint alleges as follows: In or about 2010, while housed at Pleasant Valley State Prison (“PVSP”), Plaintiff was diagnosed with Hepatitis C (“Hep-C”). Hep-C requires interferon treatment. Plaintiff was transferred to Kern Valley Sate Prison (“KVSP”) on April 12, 2012. On April 4, 2013, Plaintiff requested a medical transfer from KVSP based on the fact that Plaintiff suffers from Hep-C and should be receiving treatment. Plaintiff was evaluated on February 11, 2013 by Doctor A. Manasrah, who documented that Plaintiff was Hep-C positive. On October 17, Plaintiff submitted a “Health Care Service Request Form” stating that he was experiencing excruciating pain in the upper right side, which he believed may be related to Hep-C causing liver or kidney damage. Plaintiff was evaluated by RN J. German on December 2, 2013, who recorded that Plaintiff had a history of Hep-C. For more than three years, Plaintiff complained to Defendant Wayne Ulit that he was having excruciating pain in his upper right side and that he believed his Hep-C was getting worse. Yet, Defendant Wayne Ulit stated that he would not give Plaintiff the treatment because the medication is very expensive and Plaintiff had to be under 55 years old to receive the treatment. On or about November 29, 2016, Plaintiff was evaluated by Defendant Clement Ogbuehi. Dr. Ogbuehi reviewed Plaintiff’s medical history and discovered that Plaintiff was Hep-C positive. Plaintiff explained that he has been experiencing excruciating pain in the upper right side for four or five years and has not received any treatment. Plaintiff explained that there was a new drug that could cure Hep-C. Defendant Ogbuehi denied Plaintiff this new medication and failed to provide Plaintiff any other type of treatment, due to the expensive cost of the drug. By the time Defendants Ulit and Ogbuehi decided to treat Plaintiff for Hep-C, Plaintiff had contracted cirrhosis of the liver. On July 3, 2017, Plaintiff filed a medical appeal requesting treatment of Harvoni medication for Hep-C and cirrhosis of the liver. Plaintiff has been asking for treatment for more than five years and has not received any type of treatment. Plaintiff has had Hep-C for more than 18 years and has not received any type of treatment. Defendants stated that Plaintiff’s Hep-C was undetectable. Until fairly recently, the standard treatment regimen consisted of high doses of interferon, a virus-fighter produced by white blood cells in combination with another drug, Ribavirin. The drugs were effective in fewer than half the cases and could cause significant side effects such as anemia, hair loss, flu-like symptoms, memory loss, and liver failure. Adding a third drug to the package, Boceprevir, appeared to boost success rates somewhat, but also increased the likelihood of side effects. Starting in 2013, when Plaintiff requested treatment, the release of a new generation of direct-acting antivirals, known as ADDs, offered new hope for Hep-C patients. The new drugs are tailored to combat specific genotypes of the virus, and are more effective than interferon, resulting in virtual cure in more than 90% of patients. Plaintiff requested this new drug, Harvoni, which is a cure for Hep-C, prior to contracting cirrhosis of the liver. Defendants Ulit and Ogbuehi refused to provide Plaintiff with medications due to the cost. Now Plaintiff’s Hep-C has developed into cirrhosis of the liver. Plaintiff’s liver is heterogeneous echogenicity and exhibits a nodular surface contour consistent with cirrhosis, consisting of dissimilar or diverse ingredients of constituents; mixed. According to the ultrasound of Plaintiff’s liver, the image of the transverse and longitudinal static of the upper quadrant of the abdomen are suboptimal due to body habitus. Doctor C. Chult, a liver specialist, recommended dynamic enhanced abdominal CT, which was not ordered by Defendant Ulit or Defendant Ogbuehi. Plai

Free access — add to your briefcase to read the full text and ask questions with AI

(PC) Williams v. Ogbuehi, (E.D. Cal. 2020).

(PC) Williams v. Ogbuehi ((PC) Williams v. Ogbuehi) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Chapman v. Houston Welfare Rights Organization
441 U.S. 600 (Supreme Court, 1979)
Baker v. McCollan
443 U.S. 137 (Supreme Court, 1979)
Graham v. Connor
490 U.S. 386 (Supreme Court, 1989)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Hebbe v. Pliler
627 F.3d 338 (Ninth Circuit, 2010)
Powell v. Alexander
391 F.3d 1 (First Circuit, 2004)
Hoffman v. Applicators Sales & Service, Inc.
439 F.3d 9 (First Circuit, 2006)
Francisco Sanchez v. Esso Standard Oil Co.
572 F.3d 1 (First Circuit, 2009)
Eric Sanchez v. Duane R. Vild
891 F.2d 240 (Ninth Circuit, 1989)
John C. McGuckin v. Dr. Smith John C. Medlen, Dr.
974 F.2d 1050 (Ninth Circuit, 1992)
Toguchi v. Soon Hwang Chung
391 F.3d 1051 (Ninth Circuit, 2004)
Marsh v. County of San Diego
680 F.3d 1148 (Ninth Circuit, 2012)
Harold Hall v. City of Los Angeles
697 F.3d 1059 (Ninth Circuit, 2012)